ACRS
Price
$2.74
Change
+$0.03 (+1.11%)
Updated
Jan 14 closing price
Capitalization
296.87M
47 days until earnings call
Intraday BUY SELL Signals
ALGS
Price
$9.05
Change
-$0.19 (-2.06%)
Updated
Jan 14 closing price
Capitalization
55.69M
Intraday BUY SELL Signals
Interact to see
Advertisement

ACRS vs ALGS

Header iconACRS vs ALGS Comparison
Open Charts ACRS vs ALGSBanner chart's image
Aclaris Therapeutics
Price$2.74
Change+$0.03 (+1.11%)
Volume$398.09K
Capitalization296.87M
Aligos Therapeutics
Price$9.05
Change-$0.19 (-2.06%)
Volume$87.48K
Capitalization55.69M
ACRS vs ALGS Comparison Chart in %
ACRS
Daily Signal:
Gain/Loss:
ALGS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACRS vs. ALGS commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Hold and ALGS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ACRS: $2.74 vs. ALGS: $9.05)
Brand notoriety: ACRS and ALGS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRS: 34% vs. ALGS: 119%
Market capitalization -- ACRS: $296.87M vs. ALGS: $55.69M
ACRS [@Biotechnology] is valued at $296.87M. ALGS’s [@Biotechnology] market capitalization is $55.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 1 FA rating(s) are green whileALGS’s FA Score has 1 green FA rating(s).

  • ACRS’s FA Score: 1 green, 4 red.
  • ALGS’s FA Score: 1 green, 4 red.
According to our system of comparison, ACRS is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 3 TA indicator(s) are bullish while ALGS’s TA Score has 4 bullish TA indicator(s).

  • ACRS’s TA Score: 3 bullish, 7 bearish.
  • ALGS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than ACRS.

Price Growth

ACRS (@Biotechnology) experienced а +2.24% price change this week, while ALGS (@Biotechnology) price change was -6.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

ACRS is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACRS($297M) has a higher market cap than ALGS($55.7M). ALGS YTD gains are higher at: -2.897 vs. ACRS (-8.970). ACRS has higher annual earnings (EBITDA): -65.32M vs. ALGS (-84.01M). ALGS (99.1M) and ACRS (95.9M) have equal amount of cash in the bank . ACRS has higher revenues than ALGS: ACRS (15.7M) vs ALGS (2.65M).
ACRSALGSACRS / ALGS
Capitalization297M55.7M533%
EBITDA-65.32M-84.01M78%
Gain YTD-8.970-2.897310%
P/E RatioN/AN/A-
Revenue15.7M2.65M593%
Total Cash95.9M99.1M97%
Total DebtN/A6.07M-
FUNDAMENTALS RATINGS
ACRS: Fundamental Ratings
ACRS
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRSALGS
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ACRS
Daily Signal:
Gain/Loss:
ALGS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MBLU25.200.21
+0.84%
Morris State Bancshares, Inc.
CNLTL31.600.16
+0.51%
Connecticut Light & Power Co. (The)
HYSNF2.38N/A
N/A
Hysan Development Co., Ltd.
SWGAF221.26N/A
N/A
Swatch Group AG
GRFXY0.54-0.04
-6.68%
Graphex Group Ltd.

ACRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with STRRP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+1.11%
STRRP - ACRS
52%
Loosely correlated
-1.08%
ALGS - ACRS
41%
Loosely correlated
-2.06%
MYNZ - ACRS
40%
Loosely correlated
N/A
UFPT - ACRS
39%
Loosely correlated
+3.18%
OCUL - ACRS
38%
Loosely correlated
+6.14%
More

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with RGNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-2.06%
RGNX - ALGS
48%
Loosely correlated
-0.66%
ARWR - ALGS
47%
Loosely correlated
+0.56%
DNLI - ALGS
46%
Loosely correlated
+0.88%
SYRE - ALGS
45%
Loosely correlated
+5.17%
XNCR - ALGS
45%
Loosely correlated
+3.66%
More